Tango Therapeutics, Inc.

NASDAQ:TNGX

1.42 (USD) • At close May 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -130.302-101.744-108.176-58.235-51.972-14.095
Depreciation & Amortization 02.4151.6080.8970.7180.643
Deferred Income Tax 000000
Stock Based Compensation 019.07914.237.8331.7641.694
Change In Working Capital 0-37.966-18.493-11.345118.6741.696
Accounts Receivables 0200-20
Inventory 00000.4220
Accounts Payables 0-1.7051.0971.2321.1710
Other Working Capital -30.562-38.261-19.59-12.577119.0811.696
Other Non Cash Items -1.1990.2341.7511.3230.89-14.741
Operating Cash Flow -131.501-117.982-109.08-59.52770.074-24.803
Investing Activities:
Investments In Property Plant And Equipment 0-1.526-7.692-1.837-1.106-1.817
Acquisitions Net 00-34.091181.59700
Purchases Of Investments 0-310.574-208.504-372.361-207.540
Sales Maturities Of Investments 0353.526242.595190.76463.220
Other Investing Activites 86.126034.091-181.597-0.042.665
Investing Cash Flow 86.12641.42626.399-183.434-145.4660.848
Financing Activities:
Debt Repayment 000342.11300
Common Stock Issued 41.72380.0171.62329.9980.8840
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 5.9412.3891.61515.21280.88411
Financing Cash Flow 47.66482.4061.615357.32580.88411
Other Information:
Effect Of Forex Changes On Cash 0000038.123
Net Change In Cash 2.2895.85-81.066114.3645.49225.168
Cash At End Of Period 72.09769.80863.958145.02430.6625.168